Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.
We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.
Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update
– Continued Remediation Progress Being Made – Reiterating Prior Guidance of Informing FDA on Inspection Readiness During...Learn More
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
BUENA, N.J. , May 21, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jers...Learn More
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
– Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts – Antici...Learn More